David Moller – Biography
Last update: April 28, 2026Executive profile
David was Chief Scientific Officer at Sigilon Therapeutics, and Vice President, Business Development - Emerging Technology and Innovation at Eli Lilly.
David Moller is currentlyChief Scientific Officer and Director at Variant Bio - View - Variant Bio org chart
Venture Partner at Third Rock Ventures - View - Third Rock Ventures org chart
Create your alert
to follow the career of David Moller.
Education
David Moller has a Bachelor of Science in Biology from University of Maryland and a Fellowship in Endocrinology, Postdoctoral Research from Harvard Medical School.
They have also studied at University of Maryland :
Find more alumni from University of Maryland
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
More about David Moller
Selected links
Do you need to know more about David Moller? More results.
Participate
Social media
- David Moller on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of David Moller
The colleagues of David Moller
Company Colleagues
- At Variant Bio, David Moller has 19 colleagues including Andrew Farnum (CEO & Director), Bob More (Director)…
- At Third Rock Ventures, David Moller has 33 colleagues including Robert Tepper (Formation & Scientific Strategy), Chris Robinson (Talent)…
Homonyms
- David Moller - Deputy Managing Director, Senior Director Shared Service - DSV Road Sweden
- David Moller - Head of Engineering - RLDatix
Industry Colleagues
- In the Biotechnology industry, David Moller has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of David Moller.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for David Moller.
